Tehran University of Medical Sciences

Science Communicator Platform

Share By
The Prevalence of Tp53, Apc, and Pik3ca Gene Mutations in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis Publisher



Gheibi M ; Sadeghi S ; Hessami A ; Erfani Z ; Ghadirzadeh E ; Moosazadeh M
Authors

Source: Cancer Genetics Published:2025


Abstract

Background Despite the significant role of genetic mutations in colorectal cancer (CRC), there is considerable variability in the reported prevalence of TP53, APC, and PIK3CA mutations across different populations and CRC subtypes. Thus, this systematic review and meta-analysis aimed to assess the prevalence of TP53, APC, and PIK3CA gene mutations in CRC patients. Methods A systematic search was done in Medline/PubMed, Scopus, Embase, Web of Science, and Google Scholar from their dates of inception until September 2024. Obsevational studies reported TP53, APC, and PIK3CA mutations in CRC patients were included. The quality of the evidence was assessed using the Joanna Briggs Institute (JBI) instrument. The prevalence of each mutated gene and its 95 % confidence interval (CI) were calculated using the random effects model. Results A total of 32 studies were included comprising 7765 participants with JBI scores ranging from 7 to 9. Our findings showed that TP53 mutations were the most prevalent, detected in 51 % (95 % CI: 41–60) of cases, with a significantly higher prevalence in M-CRC (81 %, 95 % CI: 76–85), followed by APC (33 %, 95 % CI: 13–52), and PIK3CA (19 %, 95 % CI: 10–28). Conclusion This meta-analysis showed the high prevalence of TP53, PIK3CA, and APC mutations among CRC patients, with TP53 mutations being the most common among these three genes. © 2025 Elsevier B.V., All rights reserved.